发布求助
文献互助 智能选刊 最新文献

Canadian Journal of Optometry最新文献

筛选
英文 中文
Early Primary Open-Angle Glaucoma 早期原发性开角型青光眼
Canadian Journal of Optometry Pub Date : 2018-11-15 DOI: 10.15353/cjo.80.238
Austin R. Lifferth
{"title":"Early Primary Open-Angle Glaucoma","authors":"Austin R. Lifferth","doi":"10.15353/cjo.80.238","DOIUrl":"https://doi.org/10.15353/cjo.80.238","url":null,"abstract":"Glaucoma is the leading cause of irreversible blindness worldwide and is projected to affect more than 79.6 million people by 2020, over 10% of whom will be bilaterally blind.1 \u0000This multifactorial progressive optic neuropathy causes characteristic retinal nerve fiber layer damage that will eventually lead to associated glaucomatous visual field defects if left untreated. Unfortunately, these visual field defects are difficult for the patient to detect until more advanced stages and, as a result, early glaucoma is usually asymptomatic.2 \u0000This paper presents a case that is consistent with population studies that suggest that as many as half of people with glaucoma are unaware that they have the disease.3","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115595359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le PHQ-2 comme outil de dépistage de la dépression clinique dans une clinique de soins oculovisuels de première ligne PHQ-2作为一线眼科诊所临床抑郁症筛查工具
Canadian Journal of Optometry Pub Date : 2018-11-15 DOI: 10.15353/cjo.80.305
M. Dellabella, Steven H. Schwartz, Leon Nehmad
{"title":"Le PHQ-2 comme outil de dépistage de la dépression clinique dans une clinique de soins oculovisuels de première ligne","authors":"M. Dellabella, Steven H. Schwartz, Leon Nehmad","doi":"10.15353/cjo.80.305","DOIUrl":"https://doi.org/10.15353/cjo.80.305","url":null,"abstract":"Objet : Les tests de dépistage de la dépression clinique, une maladie très répandue et souvent invalidante, n’ont pas été étudiés dans les établissements de soins oculovisuels de première ligne. L’objet de la présente étude était de déterminer le pourcentage de patients d’une clinique de soins oculovisuels de première ligne en milieu urbain qui répondent positivement à l’outil de dépistage PHQ-2. Le PHQ-2 est un outil de dépistage ultra-court composé de deux questions concernant l’humeur et l’anhédonie. \u0000Méthodes : Les deux questions du PHQ-2 ont été posées (dans le cadre d’un questionnaire plus vaste qui comprenait des données sur le sexe, l’âge et l’origine ethnique) aux patients assis à la clinique de soins de première ligne du College of Optometry de la SUNY [University Eye Center] à Manhattan (New York). Au total, 739 questionnaires ont été remplis sur une période de deux mois, avec un pourcentage de réponse de 69 %. Tous les questionnaires ont été remplis de façon anonyme, et les questionnaires inachevés n’ont pas été inclus dans l’ensemble de données final. \u0000Résultats : Les données démographiques recueillies dans le cadre de cette étude reflètent celles de la population desservie par cette clinique; très diversifiée dans l’ensemble, avec une bonne représentation de chaque groupe d’âge. Treize pour cent de l’échantillon a reçu une cote de 3 ou plus, soit le seuil standard pour un résultat positif au PHQ‑2. \u0000Conclusions : Le taux de résultats positifs au PHQ-2 obtenu chez la population urbaine en soins oculovisuels de première ligne s’approche de celui que l’on trouve en médecine générale, ce qui suggère des taux semblables de dépression clinique. Par conséquent, le PHQ‑2 peut être un outil utile pour le dépistage de la dépression, mais il est important de faire un suivi en aiguillant les personnes vers un spécialiste de la santé mentale.","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122269221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amiodarone-Associated Optic Neuropathy 胺碘酮相关视神经病变
Canadian Journal of Optometry Pub Date : 2018-11-15 DOI: 10.15353/cjo.80.241
Sara Weidmayer
{"title":"Amiodarone-Associated Optic Neuropathy","authors":"Sara Weidmayer","doi":"10.15353/cjo.80.241","DOIUrl":"https://doi.org/10.15353/cjo.80.241","url":null,"abstract":"A 72-year old male presented symptomatic for unilateral inferior visual field loss, but was found to have bilateral optic neuropathy. Clinical features, an extended minimally symptomatic course and a temporal relationship to amiodarone use implicated amiodarone-associated optic neuropathy.  Serial ancillary testing analyses provided insight into this entity’s natural course.  This patient developed the greatest retinal nerve fiber layer thinning in the inferior quadrant; this may correlate with anatomically larger-diameter axons, supporting a previous publication which suggested that larger-diameter optic nerve axons are more susceptible to amiodarone-induced lipidosis. While rare, amiodarone-associated optic neuropathy may develop and cause permanent loss of visual function.","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132518118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuropathie optique associée à l’amiodarone 胺碘酮相关的视神经病变
Canadian Journal of Optometry Pub Date : 2018-11-15 DOI: 10.15353/cjo.80.303
Sara Weidmayer
{"title":"Neuropathie optique associée à l’amiodarone","authors":"Sara Weidmayer","doi":"10.15353/cjo.80.303","DOIUrl":"https://doi.org/10.15353/cjo.80.303","url":null,"abstract":"Un homme de 72 ans s’est présenté avec des symptômes de perte de champ visuel inférieur unilatéral, mais on a découvert qu’il souffrait d’une neuropathie optique bilatérale. Les caractéristiques cliniques, la survenue progressive accompagnée de très légers symptômes et la relation temporelle avec la prise d’amiodarone nous ont amenés à poser le diagnostic de neuropathie associée à l’amiodarone. Les analyses complémentaires en série ont donné un aperçu de l’évolution naturelle de cette entité. Ce patient a développé la couche de fibres nerveuses rétiniennes la plus importante dans le quadrant inférieur. Ceci peut être corrélé avec des axones de diamètre anatomiquement plus important, soutenant une publication antérieure qui suggérait que les axones des nerfs optiques de plus grand diamètre sont plus sensibles à la lipidose induite par l’amiodarone. Bien que rare, la neuropathie optique associée à l’amiodarone peut se développer et causer une perte permanente de la fonction visuelle.","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116975861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glaucome primitif à angle ouvert précoce 早期开角原发性青光眼
Canadian Journal of Optometry Pub Date : 2018-11-15 DOI: 10.15353/cjo.80.304
Austin L. Lifferth
{"title":"Glaucome primitif à angle ouvert précoce","authors":"Austin L. Lifferth","doi":"10.15353/cjo.80.304","DOIUrl":"https://doi.org/10.15353/cjo.80.304","url":null,"abstract":"Le glaucome est la principale cause de cécité irréversible dans le monde et devrait toucher plus de 79,6 millions de personnes d’ici 2020, dont plus de 10 % seront atteintes de cécité bilatérale.1Cette neuropathie optique progressive multifactorielle provoque des lésions caractéristiques à la couche de fibres nerveuses rétiniennes qui finiront par entraîner des lacunes glaucomateuses du champ visuel s’ils ne sont pas traités. Malheureusement, ces lacunes du champ visuel sont difficiles à détecter pour le patient avant les stades plus avancés et, par conséquent, le glaucome précoce est habituellement asymptomatique.2Cet article présente un cas qui concorde avec les études des populations selon lesquelles jusqu’à la moitié des personnes atteintes de glaucome ne savent pas qu’elles ont contracté la maladie.3","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127605498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lignes directrices pratiques pour les professionnels canadiens des soins oculovisuels concernant la sécheresse oculaire et la chirurgie de l’œil 加拿大眼科护理专业人员关于干眼症和眼科手术的实用指南
Canadian Journal of Optometry Pub Date : 2018-11-15 DOI: 10.15353/CJO.79.291
Paul M. Karpecki, C. L. Prokopich, L. Racine, Etty Bitton, B. Caffery, Paul Harasymowycz, Langis Michaud, Victor D. Pegado, Jean-Sébastien Dufour, Paul Neumann, Andrew Webber, John Ashkenas
{"title":"Lignes directrices pratiques pour les professionnels canadiens des soins oculovisuels concernant la sécheresse oculaire et la chirurgie de l’œil","authors":"Paul M. Karpecki, C. L. Prokopich, L. Racine, Etty Bitton, B. Caffery, Paul Harasymowycz, Langis Michaud, Victor D. Pegado, Jean-Sébastien Dufour, Paul Neumann, Andrew Webber, John Ashkenas","doi":"10.15353/CJO.79.291","DOIUrl":"https://doi.org/10.15353/CJO.79.291","url":null,"abstract":"En 2014, le Groupe de consensus canadien sur la sécheresse oculaire a publié un document intitulé Dépistage, diagnostic et prise en charge de la sécher-esse oculaire : guide pratique à l’intention des optométristes canadiens. Ce guide pratique ne traitait pas des répercussions de la sécheresse oculaire chez les personnes en voie de subir une intervention chirurgicale de l’œil ou ayant récemment subi ce genre d’intervention. La sécheresse oculaire est courante dans certaines cohortes ayant subi une intervention chirurgicale, et le contexte périopératoire pose des problèmes précis; d’une part parce qu’une intervention chirurgicale peut compliquer une sécheresse oculaire préexistante et, d’autre part, parce la sécheresse oculaire symptomatique et asymptomatique expose le patient au risque d’obtenir des résultats chirur-gicaux médiocres. Le groupe de consensus a élaboré cet addenda au guide pratique de 2014 pour offrir des conseils sur les soins relatifs à la sécheresse oculaire avant et après une intervention chirurgicale aux yeux.","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126987179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovations and Emerging Therapies in Glaucoma 青光眼的创新和新兴疗法
Canadian Journal of Optometry Pub Date : 2018-11-06 DOI: 10.15353/cjo.80.270
Chris Wroten
{"title":"Innovations and Emerging Therapies in Glaucoma","authors":"Chris Wroten","doi":"10.15353/cjo.80.270","DOIUrl":"https://doi.org/10.15353/cjo.80.270","url":null,"abstract":"It’s unclear when the progressive optic neuropathy that is glaucoma was first discovered, but it has been described in medical writings since ancient times. Hippocrates wrote of a blindness in the elderly that he called “glaykoseis.” Much later, the English ophthalmologist Richard Banister first discovered a correlation with high intraocular pressure (IOP). The invention of the ophthalmoscope by Hermann von Helmholtz in the mid-1800’s allowed the in vivo visualization of glaucomatous changes to the optic nerve for the first time, and in 1862 Franciscus Donders coined the term “Glaukoma simplex” to describe blindness resulting from elevated IOP. Shortly thereafter, the invention of the tonometer, the development of perimetry, and the use of cocaine as an anesthetic all further advanced the diagnosis of glaucoma.","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134347188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Éditorial
Canadian Journal of Optometry Pub Date : 2018-11-06 DOI: 10.15353/cjo.80.256
B. Chou
{"title":"Éditorial","authors":"B. Chou","doi":"10.15353/cjo.80.256","DOIUrl":"https://doi.org/10.15353/cjo.80.256","url":null,"abstract":"L'article principal de ce numéro porte sur un modèle de prise en charge multidisciplinaire de la conjonctivite allergique.","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"266 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133313906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interprofessional Management of Allergic Conjunctivitis 过敏性结膜炎的跨专业治疗
Canadian Journal of Optometry Pub Date : 2018-11-06 DOI: 10.15353/CJO.80.257
C. Prokopich, Michael Lee-Poyb, H. Kimc
{"title":"Interprofessional Management of Allergic Conjunctivitis","authors":"C. Prokopich, Michael Lee-Poyb, H. Kimc","doi":"10.15353/CJO.80.257","DOIUrl":"https://doi.org/10.15353/CJO.80.257","url":null,"abstract":"Ocular allergies affect a large and increasing number of people in North America. Canada’s statistics are likely to mirror those of the U.S., where up to 40% of the population is affected by ocular allergies. The symptoms and signs of ocular allergies can greatly affect productivity and have a dramatic effect on overall quality of life (QoL). Over the years, many effective treatments have been developed for the management of ocular allergies. For allergic conjunctivitis, topical ophthalmic agents include antihistamines, mast-cell stabilizers, dual-activity agents, steroids, nonsteroidal anti-inflammatory drugs, and other immune-modulating drugs. Oral antihistamines are commonly chosen by patients for all forms of allergy, including allergic conjunctivitis. This review provides a summary of the forms of ocular allergy, with a particular focus on the symptoms and signs, diagnosis, current treatment options, and impact on QoL. More importantly, through multidisciplinary collaboration, a simplified treatment algorithm is proposed for Canadian clinical practice. This algorithm provides practitioners the best possible management strategies based on an individual patient presentation, thereby maximizing treatment efficacy and minimizing the effects on tasks of daily living and QoL.","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125686536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Hiring & Managing A Millennial Workforce 招聘和管理千禧一代员工
Canadian Journal of Optometry Pub Date : 2018-08-01 DOI: 10.15353/CJO.80.260
Trudi Charest
{"title":"Hiring & Managing A Millennial Workforce","authors":"Trudi Charest","doi":"10.15353/CJO.80.260","DOIUrl":"https://doi.org/10.15353/CJO.80.260","url":null,"abstract":"The average Canadian Optometry practice is shifting. Millennial employees are quickly becoming the majority of staff in an Optometry practice. Millennials change careers more than any other previous generation so becoming a better recruiter will be a crucial business skill as you will be hiring more frequently than before.","PeriodicalId":417889,"journal":{"name":"Canadian Journal of Optometry","volume":"615 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115826855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信